date:Feb 12, 2014
nance, the number of Nestl representatives on LOrals Board of Directors will be adjusted from 3 to 2 directors
With this proposed acquisition of 50% of Galderma, Nestl will pursue its strategic development in Nutrition, Health, and Wellness, by expanding its activities to medical skin treatments, said Peter Brabeck-Letmathe, chairman of Nestl. In this respect, Nestl will create a new centre of activities in this area, through a new entity: Nestl Skin Health SA. Galderma will be the foundation o